Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Form 483
Manufacturing
After a pause, Aurobindo resumes drug shipments from India plant
Aurobindo’s Eugia Pharma division has resumed shipping drugs from a plant in India that had to pause production in the wake of an FDA inspection.
Joseph Keenan
Mar 13, 2024 3:40pm
Aurobindo's Eugia has received another FDA Form 483
Mar 4, 2024 10:34am
FDA slams Chinese API maker Sichuan Deebio with warning letter
Feb 22, 2024 9:10am
Takeda, WuXi, LianBio—Fierce Pharma Asia
Feb 16, 2024 8:24am
China's API firm Sichuan Deebio in deep trouble with the FDA
Feb 12, 2024 2:46pm
Catalent's Indiana filling plant in hot water with the FDA again
Feb 7, 2024 2:11pm